Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FAZJL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 by the Defense Logistics Agency on July 16, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract employs firm fixed-price pricing and carries an ultimate completion date of July 17, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete directly in the federal marketplace while leveraging its small business status.
This award operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military healthcare facilities worldwide. The vendor's established portfolio includes distribution of branded and generic prescription drugs, biologics, vaccines, and specialized pharmaceutical products to Department of Defense healthcare sites. Xtandi, an oncology medication, aligns with the company's demonstrated capability to supply prescription pharmaceuticals critical to federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAZJL?
SPE2DB25FAZJL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 16, 2025.
How much is contract SPE2DB25FAZJL worth?
The government has obligated $4,170 on SPE2DB25FAZJL.
Is contract SPE2DB25FAZJL an order under another contract?
Yes. SPE2DB25FAZJL is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZJL competed?
The extent of competition for SPE2DB25FAZJL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award